Sunday, August 2, 2026

Transforming Rural Areas: North Korea’s Ambitious 20X10 Development Plans Revealed

North Korea accelerates local development projects under the 20X10 Policy, aiming for improved living standards and infrastructure.

Director Na Hong-jin’s ‘Hope’ lands North American release with NEON after Cannes invite

Na Hong-jin's film *Hope* will have a North American release via NEON after its Cannes debut, showcasing unique storytelling.

Korean Innovator Wins CNCF Community Awards 2025: What This Means for Open Source in Asia

Son Seok-ho becomes the first Korean to win the CNCF Community Awards 2025, recognizing his impactful contributions to open-source projects.

News1

K-Bio shifts focus to clinical data as key trial readouts stack up in second half

Korea's biotech sector shifts focus to clinical data in H2 2023, with key results from leading companies expected to drive investor sentiment.

Discover the Future: SK Intellix Launches AI Wellness Robot NAMUHX with My Healthcare Service

SK Intellix integrates AI health consultations into its NAMUHX wellness robot, offering personalized health advice and vital sign checks.

2025 HIV/AIDS Report: New Infections Drop by 4.9% – What You Need to Know

South Korea saw a 4.9% drop in new HIV infections in 2025, with 99% of cases linked to sexual contact, highlighting the need for testing.

2026’s Game-Changer: Inventage Lab’s BioFluidic Technology Revolutionizes Antibody Drug Administration

Inventage Lab's CEO emphasizes the importance of platform technology for drug delivery systems and open innovation in the pharmaceutical industry.

K-Health Revolution: How Korean AI is Transforming Vietnam’s Healthcare Market

A South Korean digital healthcare firm secured an export deal in Vietnam, enhancing Korean AI medical services' global presence.

SK Chemicals and J2H Biotech Partner for Breakthrough MASH Treatment: What You Need to Know

SK Chemicals partners with J2H Biotech to develop J2H-1702, a treatment for metabolic-associated steatotic liver disease, enhancing drug pipeline.

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

AI Infrastructure Crisis: How Google’s Limit on Meta’s Gemini Model Highlights a Global Computing Bottleneck

Google limits Meta's AI model access due to computing shortages, impacting key projects and shifting focus to efficiency in AI usage.

Samsung Electro-Mechanics Secures 450 Million KRW MLCC Supply Deal for AI Servers: What This Means for the Tech Industry

Samsung Electro-Mechanics has signed a $290M deal for MLCCs for AI servers, aiming to expand its product portfolio and market share.

Samsung’s New Education Solutions: How the Latest AI Assistant App Transforms Learning in 2026

Samsung Electronics showcased innovative educational solutions at ISTE Live, enhancing interactive displays for personalized learning environments.

D-RAM Price Fixing: Samsung, SK Hynix, and Micron Face Lawsuit Over 700% Price Surge

U.S. consumers and businesses sue Samsung, SK Hynix, and Micron for allegedly colluding to inflate DRAM prices by 700%.

High cost keeps breakthrough VHL drug out of reach for Korean patients, oncologist says

Patients with Von Hippel-Lindau syndrome face high treatment costs, limiting access to essential drugs like Welireg, which could reduce surgeries.

Seers wins FDA clearance for wearable ECG device, accelerating U.S. expansion

Seers' mobiCARE™ ECG monitor received FDA clearance, accelerating U.S. market entry and enhancing global expansion plans.

Continuous glucose monitors linked to 62% lower risk of death in Type 1 diabetes patients, study finds

A Korean study shows continuous glucose monitoring significantly reduces complications and mortality in Type 1 diabetes patients.

Top News

- Our Sponsors Ad -

Follow us